March 20-22, 2006
Hyatt Regency Philadelphia at Penn's Landing
201 S. Christopher Columbus Blvd.
Philadelphia, PA 19106
NCI's Early Detection Research Network (EDRN) is a consortium of scientists committed to the task of translating cancer biomarker in to clinical application and for creating the needed infrastructure for validating biomarkers for clinical application. Their main objective is to detect cancers at an early stage when therapeutic options work best. They are constantly looking for ways to improve existing, identify novel biomarkers and develop methods to detect pre-malignant lesions in clinical scenarios. The workshop is sponsored by the network as a part of annual scientific meeting. It will address the biology and factors that influence carcinogenic process and explore various research fields that hold promise for early detection of cancer. Experts in various fields will discuss how such wealth of information can be applied to develop biomarkers for early detection of cancer.
Point of Contact
For additional information or questions about this event, please contact the DCP Webmaster.
Back to top